Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31801 - 31825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	MBD4	8930	upregulated	Cisplatin results in increased expression of MBD4 mRNA	3q21.3	A22204
Cisplatin	Approved Investigational	MCM10	55388	downregulated	Cisplatin results in decreased expression of MCM10 mRNA	10p13	A21499
Cisplatin	Approved Investigational	MCM2	4171	upregulated	Cisplatin results in increased expression of MCM2 mRNA	3q21.3	A22213
Cisplatin	Approved Investigational	MDM2	4193	upregulated	Cisplatin results in increased expression of MDM2 mRNA	12q15	A22203 A22205 A20427
Cisplatin	Approved Investigational	ME1	4199	downregulated	Cisplatin results in decreased expression of ME1 mRNA	6q14.2	A20427
Cisplatin	Approved Investigational	MED27	9442	downregulated	Cisplatin results in decreased expression of MED27 mRNA	9q34.13	A22204
Cisplatin	Approved Investigational	MEIS2	4212	downregulated	Cisplatin results in decreased expression of MEIS2 mRNA	15q14	A22204
Cisplatin	Approved Investigational	MELK	9833	downregulated	Cisplatin results in decreased expression of MELK mRNA	9p13.2	A22204
Cisplatin	Approved Investigational	MFSD5	84975	upregulated	Cisplatin results in increased expression of MFSD5 mRNA	12q13.13	A22204
Cisplatin	Approved Investigational	MGMT	4255	downregulated	Cisplatin results in decreased expression of MGMT mRNA	10q26.3	A22254 A22255
Cisplatin	Approved Investigational	MICU1	10367	downregulated	Cisplatin results in decreased expression of MICU1 mRNA	10q22.1	A22204
Cisplatin	Approved Investigational	MIR15B	406949	upregulated	Cisplatin results in increased expression of MIR15B mRNA	3q25.33	A22256
Cisplatin	Approved Investigational	MIR21	406991	upregulated	Cisplatin results in increased expression of MIR21 mRNA	17q23.1	A22256
Cisplatin	Approved Investigational	MIR21	406991	downregulated	[MIR21 mRNA results in decreased susceptibility to Cisplatin] which results in decreased expression of PTEN mRNA	17q23.1	A22257
Cisplatin	Approved Investigational	MIR21	406991	downregulated	[MIR21 mRNA results in decreased susceptibility to Cisplatin] which results in decreased expression of PTEN protein	17q23.1	A22257
Cisplatin	Approved Investigational	MIR22HG	84981	upregulated	Cisplatin results in increased expression of MIR22HG mRNA	17p13.3	A22204 A22211
Cisplatin	Approved Investigational	MIR22HG	84981	upregulated	Cisplatin results in increased stability of and results in increased expression of MIR22HG mRNA	17p13.3	A22245
Cisplatin	Approved Investigational	MIR23A	407010	upregulated	Cisplatin results in increased expression of MIR23A mRNA	19p13.12	A22256
Cisplatin	Approved Investigational	MIR25	407014	upregulated	Cisplatin results in increased expression of MIR25 mRNA	7q22.1	A22256
Cisplatin	Approved Investigational	MIR339	442907	upregulated	Cisplatin results in increased expression of MIR339 mRNA	7p22.3	A22256
Cisplatin	Approved Investigational	MIR374A	442919	upregulated	Cisplatin results in increased expression of MIR374A mRNA	Xq13.2	A22256
Cisplatin	Approved Investigational	MIR376C	442913	downregulated	Cisplatin results in decreased expression of MIR376C mRNA	14q32.31	A22206
Cisplatin	Approved Investigational	MIR572	693157	upregulated	Cisplatin results in increased expression of MIR572 mRNA	4p15.33	A22256
Cisplatin	Approved Investigational	MIR574	693159	upregulated	Cisplatin results in increased expression of MIR574 mRNA	4p14	A22256
Cisplatin	Approved Investigational	MIR622	693207	downregulated	Cisplatin results in decreased expression of MIR622 mRNA	13q31.3	A22256

Displaying entries 31801 - 31825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability